Magro Giuseppe
Department of Neuroscience, "Giovanni Paolo II" Hospital, Lamezia Terme, 88046 Catanzaro, Italy.
Neurol Int. 2025 Jan 19;17(1):11. doi: 10.3390/neurolint17010011.
Stage 1 Plus is defined here as a naïve, previously untreated, status epilepticus (SE) that is probably refractory to Benzodiazepines (BDZ). These cases include not only prolonged SE as previously proposed by the author (SE lasting > 10 min) but also other cases notoriously associated with BDZ refractoriness such as the absence of prominent motor phenomena and acute etiology (especially primary central nervous system etiology). Interestingly, the absence of prominent motor phenomena as is the case of non convulsive SE might implicitly fall in the category of prolonged SE due to the delay in recognition and treatment. Future studies should help identify other factors associated with BDZ refractoriness, therefore widening the definition of Stage 1 Plus. The appropriate timing for defining prolonged SE may also differ depending on different etiology. Consequently, in future tailored models of SE, the definition of prolonged SE could be enhanced by defining it for a longer duration than Tx, a time point that changes based on different etiologies (x), Tx being much shorter than 10 min in acute etiologies. These cases of naïve probably BDZ refractory SE (Stage 1 Plus) might require a different approach: combined polytherapy from the start. The objective of this review is to provide pathophysiological and pre-clinical evidence, mostly from animal studies, for the different approach of combined polytherapy from the start for those cases of SE falling in the definition of Stage 1 Plus.
1+期在此定义为初发、既往未接受过治疗的癫痫持续状态(SE),可能对苯二氮䓬类药物(BDZ)耐药。这些病例不仅包括作者之前提出的延长性SE(SE持续时间>10分钟),还包括其他与BDZ耐药密切相关的病例,如无明显运动现象和急性病因(尤其是原发性中枢神经系统病因)。有趣的是,非惊厥性SE这种无明显运动现象的情况,可能因识别和治疗延迟而隐含地属于延长性SE范畴。未来的研究应有助于确定与BDZ耐药相关的其他因素,从而拓宽1+期的定义。定义延长性SE的合适时机也可能因病因不同而有所差异。因此,在未来针对SE的定制模型中,延长性SE的定义可以通过定义比Tx更长的持续时间来强化,Tx是一个基于不同病因(x)而变化的时间点,在急性病因中Tx远短于10分钟。这些初发的可能对BDZ耐药的SE病例(1+期)可能需要不同的方法:从一开始就采用联合多药治疗。本综述的目的是主要从动物研究中提供病理生理学和临床前证据,以支持对属于1+期定义的SE病例从一开始就采用联合多药治疗的不同方法。